borderkevin1
About
Dupilumab displays long-term usefulness in a huge cohort involving treatment-refractory atopic dermatitis patients within everyday apply: 52-Week comes from the actual Dutch BioDay personal computer registry.
Dupilumab displays long-term usefulness in a huge cohort involving treatment-refractory atopic dermatitis patients within everyday apply: 52-Week comes from the actual Dutch BioDay personal computer registry.